Subscribe
Logo small
Search
Krzysztof Łanda

Delaying reimbursement decisions for cost-effective therapies is unfair

MedExpress Team

Medexpress

Published June 23, 2022 14:18

Delaying reimbursement decisions for cost-effective therapies is unfair - Header image
We talk with Krzysztof Łanda, founder of the Watch Health Care Foundation, about access to modern methods of treating female cancers and multiple myeloma.

 

  • In the case of advanced endometrial cancer, the prognosis for Polish women is currently not good. The response to treatment with standard chemotherapy is 7-14%.
  • Recently, a promising ne...

    Content locked

    To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

    If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.

Read also